Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer
Carey K. Anders(Duke University), Jonathan S. Serody(University of North Carolina at Chapel Hill), Karen P. McKinnon(Segeberger Kliniken), Hyman B. Muss(University of North Carolina at Chapel Hill), Elizabeth Claire Dees(University of North Carolina at Chapel Hill), Benjamin G. Vincent(University of North Carolina at Chapel Hill), Rachel C. Jankowitz(University of Pennsylvania), Rebecca Kaltman(George Washington University), Alexander C. Robeson(University of North Carolina at Chapel Hill), Katherine E. Reeder‐Hayes(University of North Carolina at Chapel Hill), Lisa A. Carey(University of North Carolina at Chapel Hill), Mark G. Woodcock(Medical College of Wisconsin), Luz Cuaboy(University of North Carolina at Chapel Hill), Vinay Gudena(Centre for the Observation and Modelling of Earthquakes, Volcanoes and Tectonics), Charles M. Perou(University of North Carolina at Chapel Hill), Benjamin C. Calhoun(University of North Carolina at Chapel Hill), Alec D. Wilkinson(University of North Carolina at Chapel Hill), Oleg Kolupaev(University of North Carolina at Chapel Hill), Dante S. Bortone(University of North Carolina at Chapel Hill), Sonia J. Laurie(University of North Carolina at Chapel Hill), Maria J. Sambade(University of North Carolina at Chapel Hill), Kristen Cowens(University of North Carolina at Chapel Hill), Oludamilola Olajide(Rex Hospital), Dominic T. Moore(University of North Carolina at Chapel Hill), Trevor A. Jolly(University of North Carolina at Chapel Hill), Amy Garrett(University of North Carolina at Chapel Hill), Amanda E.D. Van Swearingen(Duke Cancer Institute)
Cited by 28
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k